A Randomized, Open-label, Two-way Crossover Study to Assess the Pharmacokinetics and Safety of CK-30 600 mg (Compound K)

NCT03136770 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Pharmacokinetics

Interventions

DIETARY_SUPPLEMENT: CK-30
DIETARY_SUPPLEMENT: Red ginseng extracts

Sponsor

Seoul National University Hospital